On January 16, 2015, Tonix Pharmaceuticals Holding Corp. notified Donald Kellerman, the Company's Senior Vice President Clinical Development and Regulatory Affairs, that the Company would not renew Dr. Kellerman's employment agreement upon its expiration on March 31, 2015 and that his employment would terminate upon expiration of his employment agreement.